Treatment of cancer

Details Treatment of cancer Treatment of cancer

1986-11-28

1989-09-05

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 21, 424 11, A61K 3702, A61K 4300

Patent

active

048639028

ABSTRACT:
Antitumor effect of antitumor agents or treatments is favorably controlled by a growth factor. The growth factor enhances antitumor actions of antitumor agents or treatments including those against which tumor or cancer has acquired resistant, or reduces side effects due to the antitumor agents or treatments. The most typical growth factors include human epidermal growth factor. A lot of tumors or cancers including human ones has been tested and a lot of growth factors has been tested, and the favorable control has been determined.

REFERENCES:
patent: 4619913 (1986-10-01), Luck et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4659696 (1987-04-01), Hirai et al.
patent: 4670419 (1987-06-01), Uda et al.
Biol. Abstr., vol. 78, (1984), 57077.
Chem. Abstr., vol. 104, (1986), 179637.
Chem. Abstr., vol. 106, (1987), 15608.
Chem. Abstr., vol. 72, (1970), 10101.
Biol. Abstr., vol. 82, (1986), 18869.
Biol. Abstr., vol. 82, (1986), 94532.
Biol. Abstr., vol. 81, (1986), 97302.
Biol. Abstr., vol. 78, (1984), 57080.
Chem. Abstr., vol. 105, (1986), 1303.
Journal of Biological Chemistry, (1984), vol. 259, pp. 7761-7766.
Cancer Letters, 28, (1985), 143-150, Elsevier Scientific Publishers Ireland Ltd., Epidermal Growth Factor Stimulates the Growth of A431 Tumors in Athymic Mice. Instruction 14, Screening Data Summary Interpretation and Outline of Current Screen, Drug Evaluation Branch, National Cancer Institute, Bethesda, Md., 20014.
Europ. J. Cancer, vol. 17, pp. 129-142, Current Results of the Screening Program at the Division of Cancer Treatment, National Cancer Institute, A. Goldin, et al.
P. 87, 2-Hormone Pharmacol., vol. 86, 1977, 134034.
11913, Chemical Abstracts, vol. 86, 1977, p. 32.
Cancer Treatment Reports, vol. 67, No. 9, Sep. 1983, The National Cancer Institute Antitumor Drug Discovery Program, Current and Future Perspectives: A Commentary, John M. Venditti.
The Journal of Biological Chemistry, vol. 258, No. 8, Issue of Apr. 25, pp. 5045-5049, 1983, Purification of Insulin Receptor with Full Binding Activity, Yoko Fujita-Yamaguchi et al.
Cell, vol. 40, pp. 747-758, Apr. 1985, The Human Insulin Receptor cDNA: The Structural Basis for Hormone-Activated Transmembrane Signalling.
Clinics in Endocrinology and Metabolism, vol. 13, No. 1, Mar. 1984, Somatomedin/Insulin-Like Growth Factor Tissue Receptors, S. Peter Nissley.
Cell, vol. 22, pp. 649-655, Dec. 1980, Serum-Free Cell Culture: A Unifying Approach by David Barnes and Gordon Sato.
Trans. Assoc. Am. Physicians, 85, 279-294, (1972); Reference No. 8; A Serotoninergic Mechanism for the Control of Insulin Secretion.

Affiliated with

Also associated with

Rating

Treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-243500